Abstract:Active components of natural products, which include paclitaxel, curcumin, gambogic acid, resveratrol, triptolide and celastrol, have promising anti-inflammatory, antitumor, anti-oxidant, and other pharmacological activities. However, their clinical application is limited due to low solubility, instability, low bioavailability, rapid metabolism, short half-life, and strong off-target toxicity. To overcome these drawbacks, cell membrane-based biomimetic nanosystems have emerged that avoid clearance by the immune system, enhance targeting, and prolong drug circulation, while also improving drug solubility and bioavailability, enhancing drug efficacy, and reducing side effects. This review summarizes recent advances in the preparation and coating of cell membrane-coated biomimetic nanosystems and in their applications to disease for targeted natural products delivery. Current challenges, limitations, and prospects in this field are also discussed, providing a research basis for the development of multifunctional biomimetic nanosystems for natural products.

What problem does this paper attempt to address?

The paper primarily explores the advancements in cell membrane-based biomimetic nano-delivery systems for natural products. Specifically, the article focuses on how to utilize cell membranes (particularly red blood cell membranes and white blood cell membranes) to overcome the challenges faced by active ingredients in natural products (such as paclitaxel, curcumin, etc.) in clinical applications. These challenges include low solubility, instability, low bioavailability, rapid metabolism, short half-life, and strong non-targeted toxicity. The article first introduces the application prospects and challenges of active ingredients in natural products and proposes the potential of using cell membrane-based biomimetic nano-systems as a solution. These nano-systems can evade immune system clearance, improve targeting, extend drug circulation time, and simultaneously enhance drug solubility and bioavailability, thereby increasing efficacy and reducing side effects. Next, the paper discusses in detail the experimental basis, preparation methods, surface modification techniques, and application cases in disease treatment of red blood cell membranes (RBCM) and white blood cell membranes (WBCM) as biomimetic nano-carriers. It particularly mentions the fusion of nanoparticles with cell membranes through techniques such as physical extrusion, ultrasonic treatment, or microfluidic electroporation, and the verification of their structural and functional integrity through various characterization methods. For red blood cell membranes, the research emphasizes their role in extending blood circulation time and evading immune clearance, and introduces specific examples, such as nanoparticles coated with red blood cell membranes to load paclitaxel for enhanced anti-tumor effects. Additionally, it mentions further enhancing the specificity and therapeutic efficiency of these nano-systems through targeted modifications (e.g., using specific proteins or antibodies). For white blood cell membranes, especially macrophage membranes, the article points out that they can help nano-carriers target inflammation sites and tumor tissues, thereby achieving more effective drug delivery. Similarly, it provides examples illustrating how these properties can be utilized to develop new therapeutic strategies. In summary, the main objective of this paper is to summarize recent advancements in cell membrane-based biomimetic nano-delivery systems and to explore how these technologies can promote the effective utilization of active ingredients in natural products, particularly in enhancing efficacy and reducing toxic side effects.

Advances in cell membrane-based biomimetic nanodelivery systems for natural products